CClinicalTrials.gg
CompletedNCT00730340Updated Jun 15, 2010

Closure Method Study Following Tonsillectomy in Children

An Early Phase 1 interventional study of Closure of the Tonsillar Fossa and Tonsillectomy with open fossa in Tonsillectomy and Children, sponsored by University of Oklahoma. Completed at 1 site in United States. Open to participants aged 5 Years to 10 Years. Per ClinicalTrials.gov, last updated 2010-06-15.

Sponsored by University of Oklahoma · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
5 Years to 10 Years
Sex
All
01

Study summary

This is a children's study evaluating the effects of a tonsillectomy with tonsillar fossae closure compared to without closure of the operative wound.

Read the detailed description

This is a children's study. Patients experience significant postoperative pain, activity limitation and sometimes other significant postoperative complications. We are going to compare the effects of closing the tonsil wound versus non-closure. A daily journal will be kept (by the patient's parent or legal guardian)to log in measures of morbidity. Postoperative telephone calls will be made and scripted questions will be asked regarding any tonsillar hemorrhage requiring medical re-evaluation, and dehydration requiring medical re-evaluation. The patients will also be examined in the clinic at 10-14 days postoperatively to determine if the fossa remained closed or dehisced.

02

Conditions studied

  • Tonsillectomy
  • Children

Keywords

  • Tonsillectomy, tonsillar fossa, wound closure
03

In context

Lead sponsor

University of Oklahoma is the lead sponsor of 424 studies on the registry; 99 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 16 (38%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Normal children between that ages of five to ten requiring a tonsillectomy

Exclusion criteria

Exclusion Criteria:

  • Children older than ten years of age.
  • Those children with identified syndromes, cleft palates and velopharyngeal insufficiency will not be eligible.
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
14 participants (actual)

Study arms

  • Active comparator
    1

    Patients will receive closure of the tonsillar fossae following tonsillectomy.

    Procedure: Closure of the Tonsillar Fossa

  • Active comparator
    2

    Patients will not receive closure to one or both tonsillar fossa following a tonsillectomy

    Procedure: Tonsillectomy with open fossa

Interventions

  • ProcedureClosure of the Tonsillar Fossa

    We hypothesize that closure of the tonsillar fossa decreases the morbidity of pain by decreasing exposure of the raw operative bed to oral secretions, mediation, and oral intake, and decreases the morbidity of post-operative hemorrhage by having the operative wound closed.

  • ProcedureTonsillectomy with open fossa

    SOP for a tonsillectomy.

06

What researchers measure

Primary outcomes

  1. Decreased morbidity in children with closure of the tonsillar fossae compared with tonsillectomy without closure

    Time frame: 6 months

Secondary outcomes

  1. The patients will also be examined in the clinic postoperatively to determine if the fossae remained closed or dehisced.

    Time frame: 10-14 days postoperatively

07

Study locations

1 site
  • University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00730340
Lead sponsor
University of Oklahoma
First posted
Aug 8, 2008
Start date
Aug 2008
Primary completion
Jun 2010
Completion
Jun 2010
Last update
Jun 15, 2010

Study contacts

Wayne E Berryhill, M.D.
principal investigator · University of Oklahoma

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion